JP2004527578A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004527578A5 JP2004527578A5 JP2002592087A JP2002592087A JP2004527578A5 JP 2004527578 A5 JP2004527578 A5 JP 2004527578A5 JP 2002592087 A JP2002592087 A JP 2002592087A JP 2002592087 A JP2002592087 A JP 2002592087A JP 2004527578 A5 JP2004527578 A5 JP 2004527578A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- eye
- composition according
- inhibitor
- dry eye
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000003556 Dry Eye Syndromes Diseases 0.000 claims 3
- 206010013774 Dry eye Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 239000003112 inhibitor Substances 0.000 claims 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 2
- 238000009736 wetting Methods 0.000 claims 2
- FAWLNURBQMTKEB-URDPEVQOSA-N 213546-53-3 Chemical compound N([C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N1[C@@H](CCC1)C(O)=O)C(C)C)C(C)C)C(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)N)C(C)C FAWLNURBQMTKEB-URDPEVQOSA-N 0.000 claims 1
- FXRYWOJYVGJZLE-UHFFFAOYSA-N 4,4-dimethyl-2,3-dihydro-1,2-benzoselenazine Chemical compound C1=CC=C2C(C)(C)CN[Se]C2=C1 FXRYWOJYVGJZLE-UHFFFAOYSA-N 0.000 claims 1
- YEYAKZXEBSVURO-UHFFFAOYSA-N 4-amino-3-chloro-n-[2-(diethylamino)ethyl]benzamide Chemical compound CCN(CC)CCNC(=O)C1=CC=C(N)C(Cl)=C1 YEYAKZXEBSVURO-UHFFFAOYSA-N 0.000 claims 1
- 150000003857 carboxamides Chemical class 0.000 claims 1
- 229950008176 declopramide Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 230000017128 negative regulation of NF-kappaB transcription factor activity Effects 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 238000001356 surgical procedure Methods 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 238000011200 topical administration Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29249501P | 2001-05-21 | 2001-05-21 | |
| PCT/US2002/015859 WO2002095704A1 (en) | 2001-05-21 | 2002-05-17 | Use of nf-kappa-b inhibitors to treat dry eye disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004527578A JP2004527578A (ja) | 2004-09-09 |
| JP2004527578A5 true JP2004527578A5 (enExample) | 2005-12-22 |
Family
ID=23124921
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002592087A Pending JP2004527578A (ja) | 2001-05-21 | 2002-05-17 | ドライアイ障害を処置するためのＮＦ−κＢインヒビターの使用 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6696453B2 (enExample) |
| EP (1) | EP1393277B1 (enExample) |
| JP (1) | JP2004527578A (enExample) |
| CN (1) | CN1509462A (enExample) |
| AT (1) | ATE333273T1 (enExample) |
| AU (1) | AU2002309963B2 (enExample) |
| BR (1) | BR0209965A (enExample) |
| CA (1) | CA2447883A1 (enExample) |
| CY (1) | CY1105220T1 (enExample) |
| DE (1) | DE60213230T2 (enExample) |
| DK (1) | DK1393277T3 (enExample) |
| ES (1) | ES2263785T3 (enExample) |
| MX (1) | MXPA03010632A (enExample) |
| PL (1) | PL367286A1 (enExample) |
| PT (1) | PT1393277E (enExample) |
| WO (1) | WO2002095704A1 (enExample) |
| ZA (1) | ZA200308769B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006502183A (ja) | 2002-09-20 | 2006-01-19 | アルコン，インコーポレイテッド | ドライアイ障害の処置のためのサイトカイン合成インヒビターの使用 |
| CN112263672A (zh) * | 2020-11-04 | 2021-01-26 | 武汉益承生物科技有限公司 | 一种p55pik抑制剂在制备干眼治疗药物中的应用 |
Family Cites Families (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3991759A (en) | 1975-10-28 | 1976-11-16 | Alza Corporation | Method and therapeutic system for treating aqueous deficient dry eye |
| US4131651A (en) | 1977-10-25 | 1978-12-26 | Barnes-Hind Pharmaceuticals, Inc. | Treatment of dry eye |
| US4409205A (en) | 1979-03-05 | 1983-10-11 | Cooper Laboratories, Inc. | Ophthalmic solution |
| US4370325A (en) | 1979-03-30 | 1983-01-25 | Dermik Laboratories | Pharmaceutical compositions and method of treatment |
| US6150090A (en) | 1986-01-09 | 2000-11-21 | Massachusetts Institute Of Technology | Nuclear factors associated with transcriptional regulation |
| US4744980A (en) | 1986-04-28 | 1988-05-17 | Holly Frank J | Ophthalmic solution for treatment of dry eye syndrome |
| US4883658A (en) | 1986-04-28 | 1989-11-28 | Holly Frank J | Ophthalmic solution for treatment of dry-eye syndrome |
| US4804539A (en) | 1986-07-28 | 1989-02-14 | Liposome Technology, Inc. | Ophthalmic liposomes |
| US4818537A (en) | 1986-10-21 | 1989-04-04 | Liposome Technology, Inc. | Liposome composition for treating dry eye |
| US4966773A (en) | 1986-11-25 | 1990-10-30 | Alcon Laboratories, Inc. | Topical ophthalmic compositions containing microfine retinoid particles |
| US4914088A (en) | 1987-04-02 | 1990-04-03 | Thomas Glonek | Dry eye treatment solution and method |
| US5278151A (en) | 1987-04-02 | 1994-01-11 | Ocular Research Of Boston, Inc. | Dry eye treatment solution |
| US4996209A (en) | 1988-06-20 | 1991-02-26 | Alcon Laboratories, Inc. | Ophthalmic antiinflammatory compositions comprising S(+)-flurbiprofen |
| US5075104A (en) | 1989-03-31 | 1991-12-24 | Alcon Laboratories, Inc. | Ophthalmic carboxy vinyl polymer gel for dry eye syndrome |
| US5174988A (en) | 1989-07-27 | 1992-12-29 | Scientific Development & Research, Inc. | Phospholipid delivery system |
| US5583150A (en) | 1989-08-18 | 1996-12-10 | Alcon Laboratories, Inc. | 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic anilides for the treatment of ocular diseases |
| US5041434A (en) | 1991-08-17 | 1991-08-20 | Virginia Lubkin | Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application |
| ZA912797B (en) | 1990-05-29 | 1992-12-30 | Boston Ocular Res | Dry eye treatment process and solution |
| ATE132366T1 (de) | 1990-05-29 | 1996-01-15 | Boston Ocular Res | Zusammensetzung zur behandlung von dry eye erkrankungen |
| DE4028906A1 (de) | 1990-09-12 | 1992-03-19 | Paz Arzneimittelentwicklung | Arzneimittel sowie deren herstellung und deren verwendung bei der bekaempfung von schmerzen und/oder entzuendungen und/oder fieber an tieren und menschen |
| JP2594486B2 (ja) | 1991-01-15 | 1997-03-26 | アルコン ラボラトリーズ インコーポレイテッド | 局所的眼薬組成物 |
| ZA927277B (en) | 1991-10-02 | 1993-05-19 | Boston Ocular Res | Dry eye treatment process and solution. |
| DE4140184C2 (de) | 1991-12-05 | 1995-12-21 | Alfatec Pharma Gmbh | Akutform für ein Flurbiprofen enthaltendes Arzneimittel |
| US5958912A (en) * | 1992-04-21 | 1999-09-28 | The Schepens Eye Research Institute, Inc. | Ocular therapy in keratoconjunctivitis sicca using topically applied androgens of TGF-β |
| ATE185697T1 (de) | 1992-04-21 | 1999-11-15 | Schepens Eye Res Inst | Androgentherapie am auge beim sjögrensyndrom |
| US5290572A (en) | 1992-08-06 | 1994-03-01 | Deo Corporation | Opthalmic composition for treating dry eye |
| US5686436A (en) | 1993-05-13 | 1997-11-11 | Hiv Diagnostics, Inc. | Multi-faceted method to repress reproduction of latent viruses in humans and animals |
| US5561161A (en) | 1994-03-25 | 1996-10-01 | Oxigene, Inc. | Methods of administering and pharmaceutical formulations containing n-substituted benzamides and/or acid addition salts thereof |
| FR2718441B1 (fr) * | 1994-04-07 | 1996-06-28 | Bioxytech | Nouveaux composés de structure benzisoséléna-zoline et -zine, leur procédé de préparation et leurs applications thérapeutiques. |
| US5474979A (en) | 1994-05-17 | 1995-12-12 | Allergan, Inc. | Nonirritating emulsions for sensitive tissue |
| US6335358B1 (en) | 1995-04-12 | 2002-01-01 | President And Fellows Of Harvard College | Lactacystin analogs |
| RU2172630C2 (ru) | 1995-08-14 | 2001-08-27 | Оксиджен, Инк. | Комбинация в виде пищевой добавки или лекарства и способ лечения человека и животных с ее использованием (варианты) |
| US5696166A (en) | 1995-10-31 | 1997-12-09 | Yanni; John M. | Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders |
| WO1997020578A1 (en) * | 1995-12-04 | 1997-06-12 | University Of Miami | Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance |
| US6100299A (en) | 1996-03-08 | 2000-08-08 | Oxigene, Inc. | N-acetyl 3-chloroprocainamide, acid addition salts thereof, and methods of use |
| US6028111A (en) | 1996-03-08 | 2000-02-22 | Oxigene, Inc. | Compositions and use of benzamides and nicotinamides as anti-inflammatory agents |
| US6046185A (en) | 1996-07-11 | 2000-04-04 | Inflazyme Pharmaceuticals Ltd. | 6,7-oxygenated steroids and uses related thereto |
| US6071904A (en) | 1996-12-11 | 2000-06-06 | Alcon Laboratories, Inc. | Process for manufacturing ophthalmic suspensions |
| US5800807A (en) | 1997-01-29 | 1998-09-01 | Bausch & Lomb Incorporated | Ophthalmic compositions including glycerin and propylene glycol |
| US6043083A (en) | 1997-04-28 | 2000-03-28 | Davis; Roger J. | Inhibitors of the JNK signal transduction pathway and methods of use |
| US5916910A (en) | 1997-06-04 | 1999-06-29 | Medinox, Inc. | Conjugates of dithiocarbamates with pharmacologically active agents and uses therefore |
| US6207458B1 (en) | 1998-05-07 | 2001-03-27 | University Of Washigton/Stowers Insitute For Medical Research | Proteins capable of regulating NF-κB JNK and apoptosis pathways and methods of using the same |
| BR9906772A (pt) * | 1998-07-14 | 2000-09-26 | Alcon Lab Inc | Uso de ácido 11-(3-dimetilamino-propilideno)-6,11diidrodibenz[b,e]o xepin-2-acético para a fabricação de um medicamento para tratamento de desordens inflamatórias oftálmicas não-alérgicas e para prevenção de neovascularização ocular |
| AU3074500A (en) | 1999-01-20 | 2000-08-07 | Kyowa Hakko Kogyo Co. Ltd. | Proteasome inhibitors |
| US6254860B1 (en) | 1999-04-13 | 2001-07-03 | Allergan Sales, Inc. | Ocular treatment using cyclosporin-A derivatives |
| AU4555800A (en) | 1999-04-27 | 2000-11-10 | Novartis Ag | Use of 2,4-diamino-3-hydroxycarboxylic acid derivatives as proteasome inhibitors |
-
2002
- 2002-05-17 BR BR0209965-9A patent/BR0209965A/pt not_active IP Right Cessation
- 2002-05-17 EP EP02736994A patent/EP1393277B1/en not_active Expired - Lifetime
- 2002-05-17 CA CA002447883A patent/CA2447883A1/en not_active Abandoned
- 2002-05-17 ES ES02736994T patent/ES2263785T3/es not_active Expired - Lifetime
- 2002-05-17 CN CNA028102061A patent/CN1509462A/zh active Pending
- 2002-05-17 JP JP2002592087A patent/JP2004527578A/ja active Pending
- 2002-05-17 DK DK02736994T patent/DK1393277T3/da active
- 2002-05-17 MX MXPA03010632A patent/MXPA03010632A/es active IP Right Grant
- 2002-05-17 WO PCT/US2002/015859 patent/WO2002095704A1/en not_active Ceased
- 2002-05-17 AU AU2002309963A patent/AU2002309963B2/en not_active Ceased
- 2002-05-17 US US10/150,219 patent/US6696453B2/en not_active Expired - Lifetime
- 2002-05-17 AT AT02736994T patent/ATE333273T1/de active
- 2002-05-17 DE DE60213230T patent/DE60213230T2/de not_active Expired - Lifetime
- 2002-05-17 PT PT02736994T patent/PT1393277E/pt unknown
- 2002-05-17 PL PL02367286A patent/PL367286A1/xx not_active Application Discontinuation
-
2003
- 2003-11-11 ZA ZA2003/08769A patent/ZA200308769B/en unknown
-
2006
- 2006-09-14 CY CY20061101314T patent/CY1105220T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2335493C2 (ru) | Производные хинолина в качестве ингибиторов фосфодиэстеразы | |
| NO20034612L (no) | 3,4-di-substituerte syklobuten-1,2-dioner, farmasoytiske preparater som omfatter forbindelsene, samt anvendelse av forbindelsene for tilvirkning av medikamenter for behandling av kjemokinformidlede sykdommer | |
| JP2003503454A5 (enExample) | ||
| WO2004004648A3 (en) | Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use | |
| EA200400881A1 (ru) | Азаарилпиперазины | |
| JP2007514005A5 (enExample) | ||
| PL3889142T3 (pl) | Związki kwasu 1,2,4-oksadiazolobenzoesowego i ich zastosowanie do supresji nonsensu i do leczenia choroby | |
| WO2001062236A3 (en) | New drug combinations comprising a norepinephrine reuptake inhibitor and an antimuscarinic agent | |
| CA2436540A1 (en) | Pharmaceutical compositions based on anticholinergics and corticosteroids | |
| JP2005504782A5 (enExample) | ||
| JP2001511463A5 (enExample) | ||
| JP2004532828A5 (enExample) | ||
| JP2005508963A5 (enExample) | ||
| JP2005509503A5 (enExample) | ||
| EP1284265A4 (en) | BENZOTHIOPHENE DERIVATIVES AND MEDICINAL USE THEREOF | |
| WO2002102743A3 (de) | Deuterierte n- und alpha-substituierte diphenylalkoyxessigsäureaminoalkylester sowie diese verbindungen enthaltende arzneimittel | |
| CA2389032A1 (en) | Preventive or therapeutic agents for inflammatory diseases of intestine | |
| JP2004527578A5 (enExample) | ||
| JP2002537232A5 (enExample) | ||
| JP2003503453A5 (ja) | ガバペンチンおよびプレガバリンを含む相乗作用組成物 | |
| JP2002114686A5 (enExample) | ||
| WO2005011604A3 (en) | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease | |
| WO2005011602A3 (en) | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a pde-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease | |
| WO2002060533A3 (de) | Betamimetika enthaltende arzneimittelkompositionen mit geringere n nebenwirkungen | |
| BR0009080A (pt) | Método de tratamento da apnéia do sono |